¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Development bulletin (Australian Development Studies Network)"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • cortical peritubular capillary network
    °ÑÁú¼¼°üÁÖÀ§¸ð¼¼Ç÷°ü±×¹°, ÇÇÁú¼¼°üÁÖÀ§¸ð¼¼Ç÷°ü¸Á
  • cytokine network
    ½ÃÅäÄ«Àα׹°, ½ÃÅäÄ«ÀÎ³×Æ®¿öÅ©
  • dermal arterial network
    ÁøÇǵ¿¸Æ±×¹°, ÁøÇǵ¿¸Æ¸Á
  • deep cutaneous lymphatic capillary network
    ±íÀºÇǺθ²ÇÁ¸ð¼¼°ü±×¹°, ½ÉºÎÇǺθ²ÇÁ¸ð¼¼°ü¸Á
  • dorsal carpal network
    µîÂʼոñµ¿¸Æ±×¹°
  • elastic network
    ź·Â±×¹°, ź·Â¸Á
  • glomerular capillary network
    Å丮¸ð¼¼Ç÷°ü±×¹°, »ç±¸Ã¼¸ð¼¼Ç÷°ü¸Á
  • immune network
    ¸é¿ªÁ¶Àý¸Á
  • idiotype network
    °³º°Æ¯ÀÌÇüÁ¶Àý¸Á
  • idiotype-anti-idiotype network
    °³º°Æ¯ÀÌÇüÇ×üÁ¶Àý¸Á
  • intramuscular arterial network
    ±ÙÀ°¼Óµ¿¸Æ±×¹°, ±ÙÀ°³»µ¿¸Æ¸Á
  • lateral malleolar network
    °¡Âʺ¹»çµ¿¸Æ±×¹°, ¿ÜÃøº¹»çµ¿¸Æ¸Á
  • lymphatic capillary network
    ¸²ÇÁ¸ð¼¼°ü±×¹°, ¸²ÇÁ¸ð¼¼°ü¸Á
  • lymphatic network
    ¸²ÇÁ°ü±×¹°, ¸²ÇÁ°ü¸Á
  • medial malleolar network
    ¾ÈÂʺ¹»çµ¿¸Æ±×¹°, ³»Ãø°úµ¿¸Æ¸Á
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • lymphatic network
    ¸²ÇÁ°ü±×¹°
  • lymphatic capillary network
    ¸ð¼¼¸²ÇÁ°ü±×¹°
  • medial malleolar network
    ¾ÈÂʺ¹»çµ¿¸Æ±×¹°
  • metabolic network
    ´ë»ç¸Á
  • network
    ±×¹°, ¸Á
  • patellar arterial network
    ¹«¸­»Àµ¿¸Æ±×¹°
  • perifollicular capillary network
    ¼ÒÆ÷ÁÖÀ§¸ð¼¼Ç÷°ü±×¹°
  • perifollicular lymphatic capillary network
    ¼ÒÆ÷ÁÖÀ§¸ð¼¼¸²ÇÁ°ü±×¹°
  • plantar venous network
    ¹ß¹Ù´ÚÁ¤¸Æ±×¹°
  • subcutaneous lymphatic capillary network
    ÇǺιظ²ÇÁ¸ð¼¼°ü±×¹°
  • subependymal network
    ³ú½Ç¸·¹Ø±×¹°
  • subepithelial capillary network
    »óÇǹظð¼¼Ç÷°ü±×¹°
  • submucous arterial network
    Á¡¸·¹Øµ¿¸Æ±×¹°
  • subpapillary arterial network
    À¯µÎ¹Øµ¿¸Æ±×¹°
  • arrested development
    Á¤ÁöµÈ¹ß´Þ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • articular arterial network of knee
    ¹«¸­°üÀýµ¿¸Æ±×¹°
  • articular vascular network
    °üÀý¸Æ°ü±×¹°
  • glomerular capillary network
    Å丮¸ð¼¼Ç÷°ü±×¹°
  • idiotype network
    °³º°Æ¯ÀÌÇü Á¶Àý¸Á
  • idiotype-anti-idiotype network
    °³º°Æ¯ÀÌÇüÇ×ü Á¶Àý¸Á
  • immune network
    ¸é¿ª¸Á
  • plantar venous network
    ¹ß¹Ù´ÚÁ¤¸Æ±×¹°
  • primary capillary network
    ÀÏÂ÷¸ð¼¼Ç÷°ü±×¹°
  • primitive capillary network
    ¿ø½Ã¸ð¼¼Ç÷°ü±×¹°
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • deep network
    ±íÀº±×¹°
  • dermal arterial network
    ÁøÇǵ¿¸Æ±×¹°
  • dermal arterial network
    ÁøÇǵ¿¸Æ±×¹°
  • dorsal carpal network
    µîÂʼոñµ¿¸Æ±×¹°
  • dorsal venous network of foot
    ¹ßµîÁ¤¸Æ±×¹°
  • dorsal venous network of hand
    ¼ÕµîÁ¤¸Æ±×¹°
  • elastic network
    ź·Â±×¹°
  • glomerular capillary network
    Å丮¸ð¼¼Ç÷°ü±×¹°
  • idiotype network
    °³º°Æ¯ÀÌÇü Á¶Àý¸Á
  • idiotype-anti-idiotype network
    °³º°Æ¯ÀÌÇüÇ×ü Á¶Àý¸Á
  • immune network
    ¸é¿ª¸Á
  • interlobular lymphatic network
    ¼Ò¿±»çÀ̸²ÇÁ°ü±×¹°
  • intralobular lymphatic network
    ¼Ò¿±¼Ó¸²ÇÁ°ü±×¹°
  • intramuscular arterial network
    ±ÙÀ°¼Óµ¿¸Æ±×¹°
  • lateral malleolar network
    °¡Âʺ¹»çµ¿¸Æ±×¹°
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • Articular arterial network of knee
    ¹«¸­°üÀýµ¿¸Æ±×¹°
    [¿¾ ¿ë¾î] ½½°üÀýµ¿¸Æ¸Á
  • Patellar arterial network
    ¹«¸­»Àµ¿¸Æ±×¹°
    [¿¾ ¿ë¾î] ½½°³µ¿¸Æ¸Á
  • Calcaneal network
    ¹ß±Á»Àµ¿¸Æ±×¹°
    [¿¾ ¿ë¾î] Á¾°ñµ¿¸Æ¸Á
  • Dorsal venous network of foot
    ¹ßµîÁ¤¸Æ±×¹°
    [¿¾ ¿ë¾î] Á·¹èÁ¤¸Æ¸Á
  • Plantar venous network
    ¹ß¹Ù´ÚÁ¤¸Æ±×¹°
    [¿¾ ¿ë¾î] Á·Ã´Á¤¸Æ¸Á
  • Subepithelial lymphatic capillary network
    »óÇǹظ𼼸²ÇÁ°ü±×¹°
    [¿¾ ¿ë¾î] »óÇÇÇϸð¼¼Àӯİü¸Á
  • Subepithelial capillary network
    »óÇǹظð¼¼Ç÷°ü±×¹°
    [¿¾ ¿ë¾î] »óÇÇÇϸð¼¼Ç÷°ü¸Á
  • Arteriolar network
    ¼¼µ¿¸Æ±×¹°
    [¿¾ ¿ë¾î] ¼Òµ¿¸Æ¸Á
  • Interlobular lymphatic network
    ¼Ò¿±»çÀ̸²ÇÁ°ü±×¹°
    [¿¾ ¿ë¾î] ¼Ò¿±°£Àӯİü¸Á
  • Intralobular lymphatic network
    ¼Ò¿±¼Ó¸²ÇÁ°ü±×¹°
    [¿¾ ¿ë¾î] ¼Ò¿±³»Àӯİü¸Á
  • Perifollicular lymphatic capillary network
    ¼ÒÆ÷ÁÖÀ§¸ð¼¼¸²ÇÁ°ü±×¹°
    [¿¾ ¿ë¾î] ¼ÒÆ÷ÁÖÀ§¸ð¼¼Àӯİü¸Á
  • Perifollicular capillary network
    ¼ÒÆ÷ÁÖÀ§¸ð¼¼Ç÷°ü±×¹°
    [¿¾ ¿ë¾î] ¼ÒÆ÷ÁÖÀ§¸ð¼¼Ç÷°ü¸Á
  • Medullary peritubular capillary network
    ¼ÓÁú¼¼°üÁÖÀ§¸ð¼¼Ç÷°ü±×¹°
    [¿¾ ¿ë¾î] ¼öÁú¿ä¼¼°üÁÖÀ§¸ð¼¼Ç÷°ü¸Á
  • Dorsal venous network of hand
    ¼ÕµîÁ¤¸Æ±×¹°
    [¿¾ ¿ë¾î] ¼ö¹èÁ¤¸Æ¸Á
  • Medial malleolar network
    ¾ÈÂʺ¹»çµ¿¸Æ±×¹°
    [¿¾ ¿ë¾î] ³»°úµ¿¸Æ¸Á
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
CAS calcarine sulcus; calcific aortic stenosis; Cancer Attitude Survey; carbohydrate-active steroid; car...
CES-D Center for Epidemiological Studies of Depression [scale]
CHAS Center for Health Administration Studies
HCSD Health Care Studies Division
MSU maple sugar urine; maple syrup urine; medical studies unit; mid-stream urine; monosodium urate; myoc...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
CES-D Center for Epidemiologic Studies - Depression
CES-D Center for Epidemiologic Studies - Depression Scale
CES-D Center for Epidemiological Studies Depression
CESD Centers for Epidemiological Studies Depression Scale
EPS Electrophysiologic Studies
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • embryonic development
    ¹è ¹ß»ý
  • ensitization 1. administration of antigen to induce a primary immune response; priming; immunization. 2. exposure to allergen that results in the development of hypersensitivity. 3. the coating of erythrocytes with antibody so that they are subject to lys
    ³»¹ø
    ƯÈ÷ ¾È°Ë ¿¬ÀÇ.
  • incomplete development
    ºÒ¿ÏÀüÇÑ ¹ßÀ°
  • personality development
    ¼º°Ý ¹ß´Þ
  • psychosexual development
    Á¤½Å¼º ¹ß´Þ
  • sensory development
    °¨°¢ ¹ß´Þ, Áö°¢ ¹ß´Þ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
immunofluorescent studies <technique> A special assay that relies on the production of measurable fluorescent light. An immunofluorescent tagged antibody interacts and binds with an antigen allowing an indirect measurement of its concentration.
(27 Sep 1997)
intervention studies Epidemiologic investigations designed to test a hypothesised cause-effect relation by modifying the supposed causal factor(s) in the study population.
(12 Dec 1998)
intracardiac electrophysiology studies <cardiology, investigation> A special study that involves the placement of electrodes inside the heart to map the electrical characteristics of the heart.
This study is carried out in a specially equipped lab and is similar to a cardiac catheterisation procedure. Electrodes are placed inside the heart via a catheter placed into a vein. The electrodes are positioned near the heart's conduction system and an electrical map of the heart can be determined.
This test is often performed in those where a life-threatening cardiac arrhythmia is a problem. The location and characteristics of an arrhythmia can be determined, thus guiding medical management of the problem. Patients with Wolf Parkinson White syndrome or sick sinus syndrome may have this test as part of their evaluation.
(27 Sep 1997)
organizational case studies Descriptions and evaluations of specific health care organizations.
(12 Dec 1998)
time and motion studies The observation and analysis of movements in a task with an emphasis on the amount of time required to perform the task.
(12 Dec 1998)
electrophysiological studies <investigation> A special study that involves the placement of electrodes inside the heart to map the electrical characteristics of the heart.
This study is carried out in a specially equipped lab and is similar to a cardiac catheterisation procedure. Electrodes are placed inside the heart via a catheter placed into a vein. The electrodes are positioned near the heart's conduction system and an electrical map of the heart can be determined. This test is often performed in those where a life-threatening cardiac arrhythmia is a problem.
The location and characteristics of an arrhythmia can be determined, thus guiding medical management of the problem. Patients with Wolf Parkinson White syndrome or sick sinus syndrome may have this test as part of their evaluation.
Acronym: EPS
(14 Mar 2000)
epidemiologic studies Studies designed to examine associations, commonly, hypothesised causal relations. They are usually concerned with identifying or measuring the effects of risk factors or exposures. The common types of analytic study are case-control studies, cohort studies, and cross-sectional studies.
(12 Dec 1998)
evaluation studies Studies determining the effectiveness or value of processes, personnel, and equipment, or the material on conducting such studies. For drugs and devices, clinical trials, drug evaluation, and drug screening are available.
(12 Dec 1998)
twin studies Methods of detecting genetic aetiology in human traits. The basic premise of twin studies is that monozygotic twins, being formed by the division of a single fertilised ovum, carry identical genes, while dizygotic twins, being formed by the fertilization of two ova by two different spermatozoa, are genetically no more similar than two siblings born after separate pregnancies.
(12 Dec 1998)
feasibility studies Studies to determine the advantages or disadvantages, practicability, or capability of accomplishing a projected plan, study, or project.
(12 Dec 1998)
follow-up studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease.
(12 Dec 1998)
longitudinal studies Studies in which variables relating to an individual or group of individuals are assessed over a period of time.
(12 Dec 1998)
acromial arterial network A vascular network between the acromion and the skin of the shoulder, formed by anastomoses of the acromial branch of the suprascapular artery with the acromial branch of the thoracoacromial artery.
Synonym: rete acromiale, acromial plexus.
(05 Mar 2000)
arteriolar network A vascular network formed by anastomoses between minute arteries just before they become capillaries.
Synonym: rete arteriosum.
(05 Mar 2000)
articular network A vascular rete in the neighborhood of a joint, where such arrangements are common, enabling a collateral circulation by which blood will be supplied distal to the joint regardless of compromises resulting from joint position.
Synonym: circulus articularis vasculosus, rete vasculosum articulare, articular network.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 12 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • Development theory
    (»ý)(¶ó¸¶¸£Å©ÀÇ)ÁøÈ­·Ð
  • InterAmerican Development Bank
    ¹ÌÁÖ °³¹ßÀºÇà
  • International Bank for Reconstruction and Development
    ±¹Á¦ ºÎÈï°³¹ßÀºÇà(IBRD)ÅëĪ(the world bank)
  • International Development Association
    (UNÀÇ)±¹Á¦ °³¹ß Çùȸ(IDA)
  • development
    ¹ß´Þ;¹ßÀü;Àü°³
  • development area
    »ê¾÷ °³¹ß Áö±¸
  • economic development zone
    (Áß°øÀÇ)°æÁ¦ °³¹ß±¸
  • housing development
    Áý´ÜÁÖÅÃ(¿ëÁö);ÁÖÅôÜÁö
  • research and development
    ¿¬±¸¿Í °³¹ß
  • ribbon development
    ´ë»ó°³¹ß(µµ½Ã¿¡¼­ ±³¿Ü·Î °£¼± µµ·Î¸¦ µû¶ó ¹«Áú¼­ÇÏ°Ô »¸¾î°¡´Â ÁÖÅà °ÇÃà)
  • self development
    Àڱ⠹ßÀü(°³¹ß)
  • string development
    =RIBBON DEVELOPMENT
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á